Patrones de prescripción de los nuevos anticoagulantes orales y sus costos económicos en Colombia

Revista Colombiana de Cardiología - Tập 23 - Trang 277-285 - 2016
Jorge E. Machado-Alba1, Santiago García-Betancur1, Federico Villegas-Cardona2, Diego Alejandro Medina-Morales1
1Grupo de Investigación en Farmacoepidemiología y Farmacovigilancia, Universidad Tecnológica de Pereira–Audifarma, S.A., Pereira, Colombia
2Asociación Colombiana Médica Estudiantil (ACOME)

Tài liệu tham khảo

Ageno, 2012, Oral anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines, Chest., 141, e44S, 10.1378/chest.11-2292 Wigle, 2013, Updated guidelines on outpatient anticoagulation, Am Fam Physician., 87, 556 Gutierrez, 2011, Atrial fibrillation: diagnosis and treatment, Am Fam Physician., 83, 61 Xu, 2012, Novel anticoagulants for non-valvular atrial fibrillation, Heart Lung Circ., 21, 463, 10.1016/j.hlc.2012.04.002 Potpara, 2013, Novel oral anticoagulants in non-valvular atrial fibrillation, Best Pract Res Clin Haematol., 26, 115, 10.1016/j.beha.2013.07.008 Kansal, 2013, Cost-effectiveness of new oral anticoagulants in the prevention of stroke in patients with atrial fibrillation, Best Pract Res Clin Haematol., 26, 225, 10.1016/j.beha.2013.07.012 Riva, 2013, Novel oral anticoagulants for the prevention of venous thromboembolism in surgical patients, Thromb Res., 131, S67, 10.1016/S0049-3848(13)70026-4 Little, 2012, New oral anticoagulants: will they replace warfarin?, Oral Surg Oral Med Oral Pathol Oral Radiol, 113, 575, 10.1016/j.oooo.2011.10.006 Capodanno, 2013, Novel oral anticoagulants versus warfarin in non-valvular atrial fibrillation: a meta-analysis of 50,578 patients, Int J Cardiol., 167, 1237, 10.1016/j.ijcard.2012.03.148 O’Dell, 2012, New oral anticoagulants for atrial fibrillation: a review of clinical trials, Clin Ther, 34, 894, 10.1016/j.clinthera.2012.01.019 McManus, 2012, Thromboembolism, Am Fam Physician, 85, 188 Gómez-Outes, 2012, Dabigatran, rivaroxaban, or apixaban versus enoxaparin for thromboprophylaxis after total hip or knee replacement: systematic review, meta-analysis, and indirect treatment comparisons, BMJ, 344, e3675, 10.1136/bmj.e3675 Falck-Ytter, 2012, Prevention of VTE in orthopedic surgery patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines, Chest., 141, e278S, 10.1378/chest.11-2404 Patel, 2011, Rivaroxaban versus warfarin in nonvalvular atrial fibrillation, N Engl J Med., 365, 883, 10.1056/NEJMoa1009638 Connolly, 2009, Dabigatran versus warfarin in patients with atrial fibrillation, N Engl J Med., 361, 1139, 10.1056/NEJMoa0905561 Granger, 2011, Apixaban versus warfarin in patients with atrial fibrillation, N Engl J Med., 365, 981, 10.1056/NEJMoa1107039 Connolly, 2011, Apixaban in patients with atrial fibrillation, N Engl J Med., 364, 806, 10.1056/NEJMoa1007432 Marcus, 2010, European ancestry as a risk factor for atrial fibrillation in African Americans, Circulation., 122, 2009, 10.1161/CIRCULATIONAHA.110.958306 January, 2014, 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society, Circulation., 130, 2071, 10.1161/CIR.0000000000000040 Rao, 2014, Atrial fibrillation: a review of recent studies with a focus on those from the duke clinical research institute, Scientifica (Cairo)., 2014, 901586 Konstantinides, 2014, 2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism, Eur Heart J., 35, 3033, 10.1093/eurheartj/ehu283 Albert, 2014, Use of novel oral anticoagulants for patients with atrial fibrillation: systematic review and clinical implications, Heart Lung., 43, 48, 10.1016/j.hrtlng.2013.10.014 Gómez-Outes, 2013, Dabigatran, Rivaroxaban, or Apixaban versus Warfarin in Patients with Nonvalvular Atrial Fibrillation: A Systematic Review and Meta-Analysis of Subgroups, Thrombosis., 2013, 640723, 10.1155/2013/640723 Levy, 2014, New oral anticoagulant-induced bleeding: clinical presentation and management, Clin Lab Med., 34, 575, 10.1016/j.cll.2014.06.004 Holster, 2013, New oral anticoagulants increase risk for gastrointestinal bleeding: a systematic review and meta-analysis, Gastroenterology., 145, 10.1053/j.gastro.2013.02.041 Agnelli, 2013, New oral anticoagulants for the treatment of venous thromboembolism, Best Pract Res Clin Haematol., 151, 10.1016/j.beha.2013.07.005 Kang, 2014, Indirect treatment comparison of new oral anticoagulants for the treatment of acute venous thromboembolism, Thromb Res., 133, 1145, 10.1016/j.thromres.2014.03.035 Kerr M. Cost and benefits of Antithrombotic therapy in atrial fibrilation in England: an economic analysis based on GRASP-AF. National Health System (NHS). 2014. fecha de consulta: abril 24 del 2015. Disponible en: http://www.nhsiq.nhs.uk/media/2566750/af_economic_analysis_final.pdf Stefanini, 2013, Drug-eluting coronary-artery stents, N Engl J Med., 368, 254, 10.1056/NEJMra1210816 Huang, 2013, The efficacy and adverse reaction of bleeding of clopidogrel plus aspirin as compared to aspirin alone after stroke or TIA: a systematic review, PLoS One., 8, e65754, 10.1371/journal.pone.0065754 Hong, 2014, Dual antiplatelet therapy after noncardioembolic ischemic stroke or transient ischemic attack: pros and cons, J Clin Neurol., 10, 189, 10.3988/jcn.2014.10.3.189 Dewilde, 2014, Triple therapy for atrial fibrillation and percutaneous coronary intervention: a contemporary review, J Am Coll Cardiol., 64, 1270, 10.1016/j.jacc.2014.06.1193 Dzeshka, 2014, Anticoagulant Therapy for Atrial Fibrillation, Cardiol Clin., 32, 585, 10.1016/j.ccl.2014.07.009 Guérin, 2013, Outcomes in atrial fibrillation patients on combined warfarin & antiarrhythmic therapy, Int J Cardiol., 167, 564, 10.1016/j.ijcard.2012.01.047 Gorczyca-Michta, 2013, Prevalence and predisposing conditions for atrial fibrillation in hospitalised patients with hypertension, Kardiol Pol., 71, 352, 10.5603/KP.2013.0062 Vyssoulis, 2013, Metabolic syndrome and atrial fibrillation in patients with essential hypertension, Nutr Metab Cardiovasc Dis., 23, 109, 10.1016/j.numecd.2011.03.011 Jiří Widimský, 2012, Arterial hypertension and atrial fibrillation: Selecting antihypertensive therapy, Cor et Vasa., 54, e248, 10.1016/j.crvasa.2012.08.004 Lane, 2012, Use of the CHA2DS2-VASc and HAS-BLED scores to aid decision making for thromboprophylaxis in nonvalvular atrial fibrillation, Circulation., 126, 860, 10.1161/CIRCULATIONAHA.111.060061 Koju, 2014, Association of cardiovascular risk factors and coronary artery lesion among coronary artery disease patients, Kathmandu Univ Med J (KUMJ)., 12, 137 Aristizábal, 2012, Consideraciones prácticas para el uso de los nuevos anticoagulantes orales, Rev Colomb Cardiol., 19, 135 Machado-Alba, 2008, Prescription patterns for antilipidemic drugs in a group of Colombian patients, Rev Panam Salud Publica., 23, 179